This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice
Journal of Biomedical Science Open Access 17 April 2024
-
Targeting Mitochondrial Complex I Deficiency in MPP+/MPTP-induced Parkinson’s Disease Cell Culture and Mouse Models by Transducing Yeast NDI1 Gene
Biological Procedures Online Open Access 09 April 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Shapira, A. H. V. et al. Mitochondrial complex I deficiency in Parkinson’s disease. Lancet 1, 1269 (1989)
Related article
Shapira, A. H. V. et al. Anatomic and disease specificity of NADH CoQ, reductase (complex I) deficiency in Parkinson’s disease. J. Neurochem. 55, 2142–2145 (1990)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Drouin-Ouellet, J. Mitochondrial complex I deficiency and Parkinson disease. Nat Rev Neurosci 24, 193 (2023). https://doi.org/10.1038/s41583-023-00676-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41583-023-00676-y
This article is cited by
-
Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice
Journal of Biomedical Science (2024)
-
Targeting Mitochondrial Complex I Deficiency in MPP+/MPTP-induced Parkinson’s Disease Cell Culture and Mouse Models by Transducing Yeast NDI1 Gene
Biological Procedures Online (2024)